Shanta Bantia
Shanta Bantia publishes mostly in Molecular Biology, Epidemiology and Genetics, on topics such as Biochemical and Molecular Research, Influenza Virus Research Studies and Adenosine and Purinergic Signaling.
- World rank
- #2,643,635 of 7,710,434 ranked researchers
- Rank in United States
- #773,465 of 1,627,098
- Works
- 68
- Citations
- 2.9k
- Citations per work
- 43.2
What does Shanta Bantia research?
Shanta Bantia's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (32%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2233.0%
- Medicine2233.0%
- Life Sciences2232.4%
- Everything else2028.8%
- Physical Sciences45.8%
- Chemistry45.8%
- 1Molecular Biology25% of their works
- 2Epidemiology17% of their works
- 3Genetics9% of their works
- 4Infectious Diseases7% of their works
- 5Physiology7% of their works
- 6Organic Chemistry6% of their works
Research topics
- Biochemical and Molecular Research
- Influenza Virus Research Studies
- Adenosine and Purinergic Signaling
- Cytomegalovirus and herpesvirus research
- Chronic Lymphocytic Leukemia Research
- HIV/AIDS drug development and treatment
- Acute Lymphoblastic Leukemia research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Which keywords describe Shanta Bantia's research?
The keywords of their largest research topics: Enzyme Regulation, Nucleotide Metabolism, Therapeutic Targets, Prognostic Factors, Influenza, Virus, Adenosine Receptors and Purinergic Signalling.
- Kinin Receptor Family
- HIV Infection
- Antiretroviral Therapy
- Genomic Aberrations
- Infection
- Purinergic Signalling
- Virus
- Prognostic Factors
- Nucleotide Metabolism
- Enzyme Regulation
- Therapeutic Targets
- Influenza
- Adenosine Receptors
- Cytomegalovirus
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- Childhood Cancer
- Hereditary Angioedema
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Enzyme Regulation321 topic
- Nucleotide Metabolism321 topic
- Therapeutic Targets252 topics
- Prognostic Factors202 topics
- Influenza161 topic
- Virus161 topic
- Adenosine Receptors141 topic
- Purinergic Signalling141 topic
- Cytomegalovirus121 topic
- Infection121 topic
- Chronic Lymphocytic Leukemia111 topic
- Genomic Aberrations111 topic
- Acute Lymphoblastic Leukemia91 topic
- Antiretroviral Therapy91 topic
- Childhood Cancer91 topic
- HIV Infection91 topic
- Hereditary Angioedema61 topic
- Kinin Receptor Family61 topic
Where does Shanta Bantia work?
Shanta Bantia's main affiliation in the publication record is BioCryst Pharmaceuticals (United States), United States.
How many publications and citations does Shanta Bantia have?
OpenAlex counts 68 works and 2,938 citations for Shanta Bantia, an h-index of 26, ranking #2,643,635 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Shanta Bantia
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shanta Bantia. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.